During the past decade, Institutul de pneumoftiziologie Marius Nasta conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institutul de pneumoftiziologie Marius Nasta" #1 sponsor was "Actelion" with 4 trials, followed by "Lung Biotechnology PBC" with 2 trials sponsored, "Galapagos NV" with 1 trials sponsored, "Savara Inc." with 1 trials sponsored and "Verona Pharma plc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institutul de pneumoftiziologie Marius Nasta" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Institutul de pneumoftiziologie Marius Nasta" are "Pulmonary Arterial Hypertension" (5 trials), "Autoimmune Pulmonary Alveolar Proteinosis" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Hypertension, Pulmonary" (1 trials) and "Idiopathic Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "Institutul de pneumoftiziologie Marius Nasta" in a lesser frequency.

Most popular intervention types in "Institutul de pneumoftiziologie Marius Nasta" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Beraprost Sodium Modified Release" (2 trials), "Selexipag" (2 trials), "Ensifentrine" (1 trials) and "GLPG1205" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institutul de pneumoftiziologie Marius Nasta" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Institutul de pneumoftiziologie Marius Nasta". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Institutul de pneumoftiziologie Marius Nasta, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institutul de pneumoftiziologie Marius Nasta, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".